Evidence map›Paper›PMID 39533238›Full record

ArticleBMC public health2024

Effects of COVID-19, control measures, and program adaptation on prevention of mother-to-child HIV transmission service uptake in Central Region, Uganda.

Josephine Nakakande, Alex Daama, Henry Komakech, Christopher Bwanika, Catherine Senyimba, Phoebe Namukanja, Linda Nabitaka Kisaakye, Josephine Namatovu, Joseph Kagaayi

Abstract read
In one paragraph

Article in BMC public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Josephine NakakandeMildmay Uganda, Kampala, Uganda. drjosey12@gmail.com.
Alex DaamaDepartment of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.
Henry KomakechDepartment of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.
Christopher BwanikaMildmay Uganda, Kampala, Uganda.
Catherine SenyimbaMildmay Uganda, Kampala, Uganda.
Phoebe NamukanjaDivision of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Linda Nabitaka KisaakyeMinistry of Health, AIDS Control Program, Kampala, Uganda.
Josephine NamatovuDepartment of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.
Joseph KagaayiDepartment of Epidemiology and Biostatistics, Makerere University School of Public Health, Kampala, Uganda.

Funding

The President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention Cooperative Agreement Number GH002046-02; Name: Accelerating Epidemic Control in Mubende Region in the Republic of Uganda; Health Impact Number: 2999; CFDA Number: 93.067
6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) control measures presented impediments for prevention of mother-to-child transmission of HIV (PMTCT) programming in Uganda. Nationwide control measures implemented April-June 2020 included a public transport ban and mandatory travel permits for pregnant women to access clinics. Program adaptations instituted for continuity of services included community drug delivery and home-based DNA-PCR testing for HIV-exposed infants (HEI). We examined the effect of COVID-19 control measures and program adaptations on PMTCT service uptake in central Uganda.

methodsWe analysed data for pregnant women living with HIV (WLHIV) and HEI receiving PMTCT services in eight districts in central Uganda. We abstracted data from medical records at 96 public clinics for six months pre-lockdown (October 2019-March 2020), three months of lockdown (April-June 2020), and six months post-lockdown (July-December 2020). We measured monthly antiretroviral therapy (ART) refill attendance, health facility deliveries, and timely DNA-PCR testing of HEI for HIV (within two months of birth). We conducted segmented ordinary least squares regression of interrupted time series and adjusted for month-to-month changes using Cumby-Huizinga test. We reported results using coefficients and 95% confidence intervals (CIs).

resultsAt the start of pre-lockdown (October 2019), there were 448 deliveries, 2,676 ART refills and 556 timely HEI tests. The pre-lockdown trend for ART refills increased while deliveries and HEI tests declined. At the start of lockdown (April 2020), all indicators declined, although significantly for facility deliveries (-60; 95% CI: -102, -18). Lockdown monthly trends were positive with 68 more HEI tested per month (95% CI:42, 93) and 51 more deliveries (95% CI: 9, 94) but insignificantly negative for ART refills. At start of post-lockdown (July 2020), HEI testing declined (-28; 95%CI: -48, -8). Post-lockdown HEI testing trend was negative with 70 fewer HEI tested per month (95%CI: -79, -62) while no difference in trend for deliveries and ART refills.

conclusionCOVID-19 control measures had a significant immediate negative impact on pregnancy deliveries at health facilities. During lockdown, all service rates rapidly recovered through program adaptations, significantly for HEI testing and deliveries. Maintaining these adaptations might help restore the positive trend in timely HIV testing for HEI.

Indexed as

COVID-19HIV InfectionsInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdultFemaleHumansInfant, NewbornPatient Acceptance of Health CarePregnancyUgandaYoung AdultCountry lockdownCOVID-19Interrupted time seriesPMTCT services

Identifiers

PMID39533238
PMCPMC11558903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.